Toshihiro Maenaka
Suzuka University of Medical Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshihiro Maenaka.
The American Journal of Chinese Medicine | 2006
Toshihiro Maenaka; Kaori Tano; Satoshi Nakanishi; Hideo Tsukada; Torao Ishida
The purpose of this study was to examine whether pain-induced brain activation was suppressed by acupuncture analgesia. We investigated the suppression of the pain-induced neuronal activation in specific brain areas of three male rhesus monkeys (aged four years old) using positron emission tomography (PET), in which changes in the regional cerebral blood flow (rCBF) were examined as an index of the neuronal activation. The brain areas such as the thalamus, insula and anterior cingulate cortex were activated by heating the tail of monkeys in 47 degrees C water compared to the heating at 37 degrees C. Those activations were suppressed by electroacupuncture (EA) with a 2 sec alteration of the frequency of 4 Hz/60 Hz at the right ST36 (the upper anterior tibial muscle) and the right LI4 (the back palm between the first and second metacarpal) acupoints. Meanwhile, this EA analgesic effect was confirmed by prolonging the tail withdrawal latencies from hot water in the temperature range from 45 to 50 degrees C.These brain areas were corresponded to the pain-related areas as reported in previous studies. In conclusion, we were able to visualize the acupuncture analgesia in the CNS. We also detected the brain areas activated or inactivated by acupuncture. The areas that responded to acupuncture stimulation at 47 degrees C water were different from the regions at 37 degrees C. We consider that this difference in the response to acupuncture may support the variation of the clinical efficacy of acupuncture in patients bearing pain or other disorders.
Journal of Traditional Chinese Medicine | 2008
Toshihiro Maenaka; Masami Oshima; Yuka Itokawa; Takashi Masubuchi; Yasuyuki Takagi; Jung-Sook Choi; Torao Ishida; Yeunhwa Gu
Postprandial hyperglycemia has been reported to elicit endothelial dysfunction and provoke future cardiovascular complications. A reduction of postprandial blood glucose levels by the glucosidase inhibitor Fuscoporia obliqua was associated with a risk reduction of cardiovascular complications, but the effects of Fuscoporia obliqua on endothelial function have never been elucidated. This study is aimed to assess the efficacy of Fuscoporia obliqua on postprandial metabolic parameters and endothelial function in type 2 diabetic patients. Postprandial peak glucose (14.47 +/- 1.27 vs. 8.50 +/- 0.53 mmol/liter), plasma glucose excursion (PPGE), and change in the area under the curve (AUC) glucose after a single loading of test meal (total 450 kcal; protein 15.3%; fat 32.3%; carbohydrate 51.4%) were significantly higher in the diet-treated type 2 diabetic patients (n=14) than the age- and sex-matched controls (n=12). The peak forearm blood flow response and total reactive hyperemic flow (flow debt repayment) during reactive hyperemia, indices of resistance artery endothelial function on strain-gauge plethysmography, were unchanged before and after meal loading in the controls. But those of the diabetics were significantly decreased 120 and 240 min after the test meal. A prior administration of Fuscoporia obliqua decreased postprandial peak glucose, PPGE, and AUC glucose. The peak forearm blood flow and flow debt repayment were inversely well correlated with peak glucose, PPGE, and AUC glucose, but not with AUC insulin or the other lipid parameters. Even a single loading of the test meal was shown to impair the endothelial function in type 2 diabetic patients, and the postprandial endothelial dysfunction was improved by a prior use of Fuscoporia obliqua. Fuscoporia obliqua might reduce macrovascular complication by avoiding endothelial injury in postprandial hyperglycemic status.
Oriental Pharmacy and Experimental Medicine | 2005
Yeunhwa Gu; Yuka Itokawa; Toshihiro Maenaka; Takenori Yamashita; Norihide Mitsumoto; Kaoru Tano; Hiroyo Kondo; Insuk Choi; Torao Ishida; Takashi Nakamura; Kiyoto Saito; Kaoru Terai; Hajime Monzen; Masami Oshima; Tetsuo Takeuchi; Yuicti Mituhana; Kenichi Bamen; Kyoo Seok Ahn
In South America, natural products with unknown drug effects are used as folk remedies and for preventive medicine. Among South American natural products, we directed our attention to Propolis, which have been known as medicinal plants, and examined the mechanisms by which these substances affect antioxidant activity, anti-tumor activity and immunoresponse. When the antioxidant activities of Propolis were examined by the DPPH and Rhoudan iron methods, since Propolis contains high levels of flavonoids, it is thought that flavonoids may be responsible for the antioxidant activity in this study. In the examination of immunoenhancement activity, we measured lymphocyte versus polymorphonuclear leukocyte ratios (L/P activity). The number of lymphocytes was significantly increased in groups treated with Proplolis. Specifically, slightly high levels of were measured in mice bearing the S-180 carcinoma, after administration of Propolis. This strongly suggests that cellular immunity is especially activated by treatment with Propolis, because production of is limited to the T cells and NK cells stimulated by mitogen and sensitized antigen. shows a different extent and mechanism of action depending on the target cells. When was measured in mice bearing the S-180 carcinoma, mice treated with Propolis showed slightly higher levels as compared to the control group. This suggests that activated macrophages produce in mice treated with Prapolis, since activated macrophages and lymphocytes are the source of most . When anti-tumor action was examined using two kinds of sarcoma (Ehrlich solid carcinoma and Sarcoma-180 carcinoma), tumor-suppressive ratios after treatment with Propolis was 29.1%. When Sarcoma-180 solid carcinoma was used, tumor-suppressive ratios were 62%. Thus, Propolis showed strong anti-tumor activity against two kinds of solid carcinoma. Taken altogether, this strongly suggests that Propolis enhances original functions of macrophages and NK cells, and as a result, secondarily enhances the immune reaction and suppresses tumor growth.
Journal of Traditional Chinese Medicine | 2006
Masayuki Kanehara; Takeshi Ogirima; Kaori Tano; Toshihiro Maenaka; Torao Ishida; Bingli Zhang; Guilan Li; Xiuyun Wang; Yi Guo
대한동의병리학회 학술대회논문집 | 2005
Yeunhwa Gu; Hiroyuki Iwasa; Takeo Hasegawa; Takenori Yamashita; Masami Oshima; Toshihiro Maenaka; Ikukatsu Suzuki; Tetsuo Takeuchi; Kyoo Seok Ahn
대한동의병리학회 학술대회논문집 | 2005
Yeunhwa Gu; Yuka Itokawa; Toshihiro Maenaka; Takenori Yamashita; Kenichiro Tanaka; Koru Tano; Hiroyo Kondo; Insuk Choi; Torao Ishida; Takashi Nakamura; Kiyoto Saito; Kaoru Terai; Hajime Monzen; Masami Oshima; Tetsuo Takeuchi; Yuicti Mituhana; Kenichi Bamen; Kyoo Seok Ahn
Oriental Pharmacy and Experimental Medicine | 2005
Yeunhwa Gu; Yuka Itokawa; Toshihiro Maenaka; Takenori Yamashita; Masayuki Tajima; Kaoru Tano; Hiroyo Kondo; Insuk Choi; Torao Ishida; Takashi Nakamura; Yuichi Ukawa; Kaoru Terai; Hajime Monzen; Masami Oshima; Tetsuo Takeuchi; Yuicti Mituhana; Kenichi Bamen; Kyoo Seok Ahn
International Journal of Medicinal Mushrooms | 2005
Yeunhwa Gu; Yuuichi Ukawa; Masami Oshima; Ikukatsu Suzuki; Toshihiro Maenaka; Insuk Choi
대한동의병리학회 학술대회논문집 | 2006
Yeunhwa Gu; Yuka Itokawa; Masahiro Iwasa; Hiroyuki Iwasa; Takashi Nakamura; Toshihiro Miura; Masami Oshima; Toshihiro Maenaka; Torao Ishita; Kaori Tano; Ikukatsu Suzuki; Takeo Hasegawa; Tetsuo Takeuchi; Kyoo Seok Ahn
대한동의병리학회 학술대회논문집 | 2006
Yeunhwa Gu; Yuka Itokawa; Takashi Masubuchi; Masami Oshima; Takashi Nsakamura; Toshihiro Maenaka; Torao Ishita; Kaori Tano; Yuri Kurono; Hiroyuki Sekimoto; Tetsuo Takeuchi; Kyoo Seok Ahn